Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood cancer patients. Listen to Story Qartemi is India's second CAR-T cell therapy ...

Later, they also took blood samples from the mice to understand how the microplastics had interacted with cells in the bloodstream. And they conducted behavioral experiments to test whether the ...